285 related articles for article (PubMed ID: 10077736)
1. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
[TBL] [Abstract][Full Text] [Related]
2. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
Yokota S; Hikasa Y; Mizushima H
Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
[TBL] [Abstract][Full Text] [Related]
3. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
Matsukawa T; Hikasa Y
Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
[TBL] [Abstract][Full Text] [Related]
4. Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.
Yokota S; Hikasa Y; Shimura I; Kusunose S
Am J Vet Res; 2013 Mar; 74(3):395-402. PubMed ID: 23438114
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
6. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.
Mustonen P; Savola J; Lassila R
Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789
[TBL] [Abstract][Full Text] [Related]
7. Adrenaline inhibits adenosine diphosphate induced intravascular aggregation of rat platelets through stimulation of alpha 2 adrenoceptors.
Oyekan AO; Botting JH
Cardiovasc Res; 1991 May; 25(5):431-7. PubMed ID: 1677313
[TBL] [Abstract][Full Text] [Related]
8. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
9. Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation.
Petrusewicz J; Kaliszan R
Gen Pharmacol; 1991; 22(5):819-23. PubMed ID: 1662170
[TBL] [Abstract][Full Text] [Related]
10. The effects of imidazoline agents on the aggregation of human platelets.
Pinthong D; Songsermsakul P; Rattanachamnong P; Kendall DA
J Pharm Pharmacol; 2004 Feb; 56(2):213-20. PubMed ID: 15005880
[TBL] [Abstract][Full Text] [Related]
11. Effects of imidazoline antagonists of alpha 2-adrenoceptors on endogenous adrenaline-induced inhibition of insulin release.
Hiyoshi Y; Miura H; Uemura K; Endo H; Ozawa K; Maeda N; Tamagawa T; Iguchi A
Eur J Pharmacol; 1995 Dec; 294(1):117-23. PubMed ID: 8788423
[TBL] [Abstract][Full Text] [Related]
12. The effects of alpha adrenergic agents on human platelet aggregation.
Hsu CY; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707
[TBL] [Abstract][Full Text] [Related]
13. Effect of imidazoline drugs on human blood platelet aggregation.
Petrusewicz J; Kaliszan R
Thromb Haemost; 1985 Dec; 54(4):784-7. PubMed ID: 2868542
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
Villeneuve A; Berlan M; Lafontan M; Montastruc JL
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047
[TBL] [Abstract][Full Text] [Related]
15. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
16. Studies on alpha 2-adrenoceptors in rabbits with perinephritis hypertension.
Hamilton CA; Reid JL; Jones CR
J Hypertens; 1986 Feb; 4(1):77-83. PubMed ID: 2870119
[TBL] [Abstract][Full Text] [Related]
17. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
18. Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs.
Petrusewicz J; Kaliszan R
Pharmacology; 1986; 33(5):249-55. PubMed ID: 3797465
[TBL] [Abstract][Full Text] [Related]
19. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of adrenaline-induced platelet aggregation by the alpha-adrenoceptor blocking drug benextramine.
Belleau B; Benfey BG; Melchiorre C; Montambault M
Br J Pharmacol; 1982 Jun; 76(2):253-7. PubMed ID: 6124293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
